NVCT Earnings Date: Nov 3, 2026 (Estimated) — Nuvectis Pharma, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is NVCT's next earnings date?
Nuvectis Pharma, Inc. (NVCT) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.22.
How did NVCT do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Nuvectis Pharma, Inc. posted EPS of -$0.30 versus the -$0.26 estimate, a miss of 15.4%. Revenue was $0. The stock's 1-day post-earnings move was -6.9%.
How much does NVCT stock move after earnings?
NVCT beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | -0.26 | -0.30 | -15.38% | $0 | ❌ Miss | -6.94% | -12.62% | +6.76% |
| 2026-05-05 | Q1 2026 | -0.31 | -0.26 | +16.13% | $0 | ✅ Beat | +9.22% | +24.41% | +4.72% |
| 2026-02-11 | Q4 2025 | -0.28 | -0.31 | -10.71% | $0 | ❌ Miss | +0.46% | -1.26% | +3.20% |
| 2025-11-04 | Q3 2025 | -0.24 | -0.44 | -83.33% | $0 | ❌ Miss | -7.55% | -4.56% | +0.31% |
| 2025-08-05 | Q2 2025 | -0.25 | -0.30 | -20.00% | $0 | ❌ Miss | -5.35% | -15.91% | -12.89% |
| 2025-02-25 | Q4 2024 | -0.28 | -0.36 | -28.57% | $0 | ❌ Miss | -5.84% | -16.58% | +17.93% |
| 2024-11-05 | Q3 2024 | -0.25 | -0.24 | +4.00% | $0 | ✅ Beat | +17.75% | +71.32% | -23.61% |
| 2024-08-06 | Q2 2024 | -0.26 | -0.26 | +0.00% | $0 | ➖ Inline | -5.83% | -10.38% | -5.97% |
Showing last 8 quarters.